Docca Pty Ltd

Docca Pty Ltd, based in Australia, operates an AI-driven clinical documentation platform, enhancing efficiency in healthcare documentation for clinicians by providing tools that streamline the creation of essential reports. Founded in 2025 in Sydney, Australia, Docca Pty Ltd specializes in clinical documentation solutions for healthcare professionals. The company has secured USD 125,000 through a pre-seed funding round from investor Antler. It has completed one deal to date, with the most recent funding round occurring on May 30, 2025.

Docca offers an AI-powered clinical documentation platform designed to assist Australian clinicians in streamlining their documentation processes. The platform includes a range of tools for generating progress notes, treatment plans, assessments, and multidisciplinary reports efficiently. It features a library of templates that comply with Australian healthcare standards, catering to various medical fields such as aged care and mental health, serving individual practitioners and clinics throughout Australia while supporting compliance across multiple languages. Docca's revenue model is subscription-based, accommodating solo practitioners, small clinics, and larger organizations.

Individual users can access a free tier, while monthly subscriptions are priced at USD 39 for solo practitioners, USD 59 for small clinics, and USD 199 for larger organizations. Each subscription grants access to the platform's core features, such as document generation and a comprehensive template library, facilitating collaborative workflows among clinicians. In May 2025, Docca Pty Ltd raised USD 125,000 in pre-seed funding, which will be utilized to develop new features and enhance their platform. The company plans to launch additional products aimed at improving documentation efficiency by late 2025.

Furthermore, Docca aims to expand its services into new markets, specifically targeting regions in Southeast Asia, with plans to establish a presence there by 2026.